Page last updated: 2024-11-06

benzimidazole and Graft vs Host Disease

benzimidazole has been researched along with Graft vs Host Disease in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forés, R1
Sanjuán, I1
Portero, F1
Ruiz, E1
Regidor, C1
López-Vélez, R1
Linares, M1
Gil, S1
Ojeda, E1
Krsnik, I1
Bautista, G1
Vallejo, C1
García-Marco, J1
Fernández, MN1
Cabrera, JR1

Other Studies

1 other study available for benzimidazole and Graft vs Host Disease

ArticleYear
Chagas disease in a recipient of cord blood transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:2

    Topics: Adult; Benzimidazoles; Chagas Disease; Cord Blood Stem Cell Transplantation; Fatal Outcome; Graft vs

2007